[The validation of the use of thymic preparations in tuberculous infection by experimental data].
Demidov
S V
SV
Miasnikov
V G
VG
Chernushenko
E F
EF
Osipova
L S
LS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D004151:Dipeptides; D004353:Drug Evaluation, Preclinical; D007107:Immune System / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D051379:Mice; D008808:Mice, Inbred CBA; D010455:Peptides / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D004151:Dipeptides; D010455:Peptides; D013949:Thymus Extracts; D013951:Thymus Hormones; C059606:iilozen; C060736:thymogen; C032805:thymalin
Obonosvanie primeneniia preparatov timusa pri tuberkuleznoĭ infektsii po dannym éksperimenta.